Acute Coronary Syndrome Market H2 2016 covering Companies illuminated by New Report

 Salvatore Klein
  2nd-Dec-2016
 112
HWO_1480678116_1.jpg

Acute coronary syndrome is a term used for conditions brought on by sudden, reduced blood flow to the heart. Symptoms include chest pain, pain elsewhere in the body, such as the left upper arm or jaw, nausea, vomiting and shortness of breath. Risk factors include age, high blood pressure, high blood cholesterol, cigarette smoking and Type 2 diabetes. Treatment includes beta blockers, calcium channel blockers, cholesterol-lowering drugs and angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBS).

Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/146223 .

Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Acute Coronary Syndrome – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Acute Coronary Syndrome (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Acute Coronary Syndrome (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Acute Coronary Syndrome and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 1, 6, 3, 9 and 1 respectively.Acute Coronary Syndrome.

Acute Coronary Syndrome (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Browse the complete report @ http://www.orbisresearch.com/reports/index/acute-coronary-syndrome-pipeline-review-h2-2016 .

Companies Mentioned:
advanceCor GmbH
Arena Pharmaceuticals, Inc.
Ascendia Pharmaceuticals LLC
Athera Biotechnologies AB
Bayer AG
Cardiome Pharma Corp.
Cerenis Therapeutics Holding SA
CSL Limited
Esperion Therapeutics, Inc.
HitGen LTD
Japan Tobacco Inc.
Lee's Pharmaceutical Holdings Limited
LipimetiX Development Inc
MedImmune LLC
Pfizer Inc.
The Medicines Company
Verseon Corporation

If you have any enquiry before buying a copy of this report @ http://www.orbisresearch.com/contacts/enquiry-before-buying/146223 .

List of Figures
Number of Products under Development for Pompe Disease, H2 2016 9
Number of Products under Development for Pompe Disease - Comparative Analysis, H2 2016 10
Number of Products under Development by Companies, H2 2016 11
Number of Products under Investigation by Universities/Institutes, H2 2016 12
Comparative Analysis by Clinical Stage Development, H2 2016 14
Comparative Analysis by Early Stage Products, H2 2016 15
Assessment by Monotherapy Products, H2 2016 29

Contact sales@orbisresearch.com for more information.

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas - 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +912064101019

Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

Follow us on Twitter: https://twitter.com/orbisresearch

Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115

Domain: Business
Category:
Posted By: Salvatore Klein and Contact Salvatore Klein
weSRCH App on Apple

Recent Press Releases

Trash Rakes Market Forecast, Growth ...

Trash rakes have always been a part of hydroelectric power plants, preventing debris from entering the plant. Over the years, the trash rakes have gained increasing demand in water

18 October, 2019

Induction Sealing Machine Market For...

The induction sealing machines are used for cap sealing and threading of caps—both plastic as well as aluminum—of packaged products offered in the plastic bottles and

18 October, 2019

Acoustic Emission Testing Market Gro...

Acoustic emission testing is used for the analysis and detection of acoustic signals in order to gain valuable information regarding discontinuity in a material and its origin. Aco

18 October, 2019